Sponsored by:
Special Acknowledgement to Richard Spaide, M.D. Dr. Spaide practices at VRMNY and specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the
Biography Dr. Graham Chung earned his bachelor of science in chemistry with an emphasis in forensic science at the University of California, Davis. During his gap years prior to optometry school, he worked as a technician and optician at two private practices in the Sacramento area. He earned his optometry degree from University
Biography Dr. Rachel Velez is a Clinical Instructor at the University Eye Center. She received her Doctor of Optometry from the New England College of Optometry in Boston, Massachusetts. She went on to complete a residency in Vision Therapy and Rehabilitation at SUNY College of Optometry. Her areas of interest include strabismus, amblyopia,
Biography Dr. Sweta Das currently serves as a clinical assistant professor at SUNY College of Optometry committed to providing premier care to patients and remaining at the forefront of advancements in eye care technology. She completed a Primary Care residency at the Northeastern State University Oklahoma College of Optometry in 2022 and is
References Gäckle HC, Lang GE, Freissler KA, Lang GK. Chorioretinopathia centralis serosa. Klinische, fluoreszeinangiographische und demographische Aspekte [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]. Ophthalmologe. 1998;95(8):529-533. doi:10.1007/s003470050310.Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1986;84:799-845.Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular
ConclusionAlthough the presentations of CSCR can be quite typical, it is important to rule out infectious and inflammatory etiologies, including white dot syndrome, for appropriate management in patients who present atypically.In the absence of active central serous chorioretinopathy, careful observation with periodic eye exams is appropriate with patient education on use of Amsler grid
Other Treatment and Management of Chronic CSCR Transpupillary thermal therapy (TTT) is being investigated as it has a diode laser that has a wavelength of 810 nm, mainly absorbed by the choroid, allowing an effective treatment of pachychoroid disease.Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents have also been studied because even though there
Treatment and Management of Chronic CSCR Verteporfirin photodynamic therapy (PDT) is generally the first recommendation for chronic CSCR. The verteporfirin dye releases free radicals once illuminated that damages the endothelium of the RPE, and is thought to reduce the choroidal vasculature hyperpermeability and extravascular leakage by changing the overall vasculature of the choroid.Suprathreshold laser photocoagulation
Differential Diagnoses Central Serous Chorioretinopathy (CSCR): This condition affects men more than women. Fundus Autofluorescence (FAF) images of our patient showed classic descending tract in the right eye which is created by the presence of subretinal fluid in CSCR. The FAF image of the left eye showed remarkable pigmentary change around the left optic nerve.
Typical Presentation of CSCR A. Color fundus photograph of left eye without apparent ovoid elevation of retina in the region of CSCR.B. Fundus autofluorescence image of left eye with trace hyper autofluorescence demarcation temporal to fovea in the region of CSCRC. OCT scan through left macula showing subretinal fluid and elevation of
